Search Results
Nonsteroidal mineralocorticoid receptor antagonists & cardiorenal outcomes in chronic kidney disease
The Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease
Jasleen Ghuman, MD - Mineralocorticoid Receptor Antagonism in Chronic Kidney Diseases
Mineralocorticoid Receptor Antagonism in Proteinuric Kidney Disease with Dr. J. Matt Luther
Mineralocorticoid Antagonists in CKD - Prof. P. Rossignol, Dr. L. A. Mortensen, Prof. M. Walsh
Addressing cardiorenal outcomes in CKD and T2D: What are the key considerations for daily practice?
Jennifer Green, EASD 2022: Finerenone & Empagliflozin in patients with CKD and T2D: CONFIDENCE Study
Mineralocorticoid Receptor Antagonists: Are They All Created Equal?
Nonsteroidal Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
FIDELIO BLOCK-CKD Dr. Bakris (Chicago)
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
Finerenone Medication Review
